A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas
Jimmy Ruiz(Wake Forest University), Glenn J. Lesser(Virginia Commonwealth University), Volker W. Stieber(Southeast Clinical Oncology Research Consortium), Stephen B. Tatter(Atrium Health Wake Forest Baptist), Kevin P. McMullen(Radiation Oncology Associates), Edward G. Shaw(Wake Forest University), Richard P. McQuellon(Wake Forest University), Thomas L. Ellis(Wake Forest University), Robin Rosdhal(Wake Forest University), Doug Case(Wake Forest University), G. Enevold(Wake Forest University)
Cited by 13
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward
|Proceedings of the National Academy of Sciences|2015|239
Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis
|Journal of neurosurgery|2010|173